JOM

Investigating biomarkers associated with mortality in patients receiving VA-ECMO for cardiogenic shock: a systematic review

By JOM Staff

07.09.26

Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is a life-sustaining therapy for severe refractory cardiogenic shock. Although VA-ECMO provides various degrees of cardiopulmonary support, mortality rates remain high. Serum biomarkers have potential to identify the rising risk of mortality in patients receiving ECMO, but evidence supporting their prognostic value is inconsistent.